Skip to content

Comprehensive analysis of senescence-associated secretory phenotype-related signature for predicting prognosis and immunotherapy response in cervical cancer.

Aug 2026 · Computer Methods in Biomechanics and Biomedical Engineering · pp. 1-19 · 0 citations · 53 references
Medicine

Abstract

Cervical cancer (CESC) is a common malignancy in women. The senescence-associated secretory phenotype (SASP) contributes to tumor progression. We developed and validated a 7-gene SASP-related prognostic signature (PTPRB, RBM38, WNT3A, TNF, SPP1, ROR1, and MEIS2) using TCGA and GEO datasets. Patients in the low-risk group exhibited a more favorable prognosis and distinct immune infiltration patterns. TIDE analysis indicated a more favorable predicted immunotherapy response in the low-risk group. Single-cell analysis demonstrated distinct expression patterns of prognostic genes across cell types. This signature may help predict prognosis and therapeutic response in CESC patients.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.